For the First Time, Alzheimer's Drug Will be Funded in NZ

by Rajshri on  May 6, 2010 at 9:55 PM Drug News
RSS Email Print This Page Comment
Drug-buying agency Pharmac has announced that for the first time a medicine specifically targetting Alzheimer's Disease and dementia will be funded in New Zealand.
 For the First Time, Alzheimer's Drug Will be Funded in NZ
For the First Time, Alzheimer's Drug Will be Funded in NZ

Pharmac revealed that it plans to buy the Donepezil Rex brand of medicines after the drug is registered with medicines safety regulator Medsafe. This decision was made because evidence indicates drugs belonging to the class of acetylchlorinesterase inhibitors may slow the progression of Alzheimer's in some patients.

Donepizil will become available without restriction to an estimated 15,000 people in the country after Pharmac managed to reduce the $32 million price tag on the drug by 95%.


Source: Medindia
RAS

Post your Comments

Comments should be on the topic and should not be abusive. The editorial team reserves the right to review and moderate the comments posted on the site.
* Your comment can be maximum of 2500 characters
Notify me when reply is posted
I agree to the terms and conditions

More News on:

Drug Toxicity Signature Drug Toxicity Creutzfeldt-Jakob Disease Diet and Alzheimer´s Disease Genetics of Alzheimer´s disease 

News A - Z

A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

News Search

Medindia Newsletters

Subscribe to our Free Newsletters!

Terms & Conditions and Privacy Policy.

Stay Connected

  • Available on the Android Market
  • Available on the App Store

Facebook

News Category

News Archive